Compare Lustrum:KISSEI PHARMACEUTICAL CO.,LTD.:4547

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index KISSEI PHARMACEUTICAL CO.,LTD. Go to web site 4547 Medicals 東証プライム March 1, 2000 1988.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents
(Percent)
25,893down
(11.7%)down
30,013up
(12.6%)up
20,456down
(7.6%)down
36,329up
(15.7%)up
26,325
(12.3%)
Other Current AssetsHelp
(Percent)
74,748up
(33.8%)up
69,329down
(29.1%)up
72,509up
(27.0%)up
60,348down
(26.0%)down
69,457
(32.5%)
Tangible Fixed AssetsHelp
(Percent)
24,579up
(11.1%)up
24,074down
(10.1%)up
24,290down
(9.0%)down
24,605down
(10.6%)down
25,503
(11.9%)
Intangible Fixed AssetHelp
(Percent)
1,507down
(0.7%)up
1,569down
(0.7%)up
1,640up
(0.6%)down
1,511down
(0.7%)down
1,519
(0.7%)
Investments and OthersHelp
(Percent)
94,473down
(42.7%)down
113,102down
(47.5%)down
149,966up
(55.8%)up
109,001up
(47.0%)up
90,718
(42.5%)
Total AssetsHelp
(Percent)
221,200
(100%)
238,087
(100%)
268,861
(100%)
231,794
(100%)
213,522
(100%)
Total Current LiabilitiesHelp
(Percent)
26,983down
(12.2%)down
36,474down
(15.3%)down
49,546up
(18.4%)up
39,315up
(17.0%)up
29,329
(13.7%)
Total Long-term LiabilitiesHelp
(Percent)
317up
(0.1%)up
227
(0.1%)
0
-
13down
(0.0%)down
1,930
(0.9%)
Shareholder's EquityHelp
(Percent)
193,900down
(87.7%)up
201,386down
(84.6%)up
219,315up
(81.6%)down
192,466up
(83.0%)down
182,263
(85.4%)
Total LiabilitiesHelp
(Percent)
221,200
(100%)
238,087
(100%)
268,861
(100%)
231,794
(100%)
213,522
(100%)

KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales
(Percent)
67,493
(100%)
65,381
(100%)
69,044
(100%)
63,234
(100%)
72,297
(100%)
Total Sales
(Percent)
67,493
(100%)
65,381
(100%)
69,044
(100%)
63,234
(100%)
72,297
(100%)
Cost of SalesHelp
(Percent)
35,118up
(52.0%)down
34,143down
(52.2%)down
36,321up
(52.6%)up
28,340up
(44.8%)up
26,735
(37.0%)
Other Costs and RevenueHelp 21,846up
(32.4%)up
18,316down
(28.0%)down
27,438down
(39.7%)down
32,076down
(50.7%)down
40,081
(55.4%)
Total CostsHelp 56,964 52,459 63,759 60,416 66,816
Net RevenueHelp 32,375up
(48.0%)up
31,238down
(47.8%)up
32,723down
(47.4%)down
34,894down
(55.2%)down
45,562
(63.0%)
Earnings Before TaxHelp 13,680down
(20.3%)down
16,507up
(25.2%)up
7,476up
(10.8%)up
4,630down
(7.3%)down
7,121
(9.8%)
Net IncomeHelp 10,529down
(15.6%)down
12,922up
(19.8%)up
5,285up
(7.7%)up
2,818down
(4.5%)down
5,481
(7.6%)
当期純利益 10,529 12,922 5,285 2,818 5,481

KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期 KISSEI PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
-6,680down
(-66.0%)down
1,533up
(12.5%)up
-2,543down
(-16.0%)down
13,933up
(96.6%)down
6,346
(100.0%)
Investing Cash Flow(ICF)Help
(Percent)
6,001down
(59.3%)down
10,776up
(87.5%)up
-9,329down
(-58.8%)down
490up
(3.4%)up
-2,087
(-32.9%)
Financing Cash FlowHelp
(Percent)
-3,420down
(-33.8%)down
-2,756up
(-22.4%)up
-4,000up
(-25.2%)up
-4,419down
(-30.6%)up
-2,306
(-36.3%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
-21down
(-0.2%)down
4
(0.0%)
0
-
0
-
1
(0.0%)
Net Increase and Decrease in Cash and Cash Equivalentsn -4,120down
(-40.7%)down
9,557up
(77.6%)up
-15,872down
(-100.0%)down
10,004up
(69.4%)up
1,954
(30.8%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

KISSEI PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

BIOFERMIN PHARMACEUTICAL CO.,LTD.
Kidswell Bio Corporation
Fuso Pharmaceutical Industries, Ltd.
STELLA PHARMA CORPORATION
MediciNova,Inc
PeptiDream Inc.
WAKAMOTO PHARMACEUTICAL CO.,LTD.
Nxera Pharma Co., Ltd.
ROHTO PHARMACEUTICAL CO.,LTD.
KAINOS Laboratories,Inc.